Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOKITO-1B tenofovir bone and kidney toxicity study in chronic hepatitis B
NL-OMON35480Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 cohorts), sponsored by Erasmus MC. Primary endpoint: Occurrence of kidney proximal tubular dysfunction. Planned start Jan 2012; status: not yet recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON35480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35480.